Primary intracranial smooth muscle tumors in immunocompromised patients
Clinical Neuropathology · 2025
DOI: 10.5414/np301675 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Neuropathology, 2025. Verfasst von Hema A Venkatappa und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Brain Neoplasms, Immunocompromised Host, Leiomyoma, Leiomyosarcoma.
Abstract (Originalsprache)
Primary intracranial smooth muscle tumors are rare and range from benign to malignant. We report 2 patients with primary intracranial smooth muscle neoplasms in immunocompromised host, 1 patient each with primary intracranial leiomyoma and primary intracranial leiomyosarcoma, both of whom clinically and radiologically mimicked meningioma. Both patients were human immunodeficiency virus (HIV) positive. Hence, smooth muscle neoplasms should be considered in the differential diagnosis of well-circumscribed intracranial lesion, especially in immunocompromised patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Venkatappa, H. A., Rao, S., Mahadevan, A., & Kodaiyarasan, P. (2025). Primary intracranial smooth muscle tumors in immunocompromised patients. Clinical Neuropathology. https://doi.org/10.5414/np301675
Vancouver
Venkatappa HA, Rao S, Mahadevan A, Kodaiyarasan P. Primary intracranial smooth muscle tumors in immunocompromised patients. Clinical Neuropathology. 2025. doi:10.5414/np301675
BibTeX
@article{Venkatappa2025,
author = {Venkatappa, Hema A and Rao, Shilpa and Mahadevan, Anita and Kodaiyarasan, Pari},
title = {Primary intracranial smooth muscle tumors in immunocompromised patients},
journal = {Clinical Neuropathology},
year = {2025},
doi = {10.5414/np301675}
}
EUVIMED